Independent
Tenure on this board
4.9 yrs
3 nominees · 3 ballot items.
Election of three Class I directors; ratification of EisnerAmper LLP as independent registered public accounting firm for 2025; amendment to the 2021 Equity Incentive Plan increasing the share reserve by 3,500,000.
Nominated slate of Class I directors Peter Diamandis, M.D., Diane Parks and Geoffrey Ling, M.D. to hold office as Class I directors until the 2028 annual meeting and until their successors are duly elected and qualified; voting by plurality; non-discretionary item.
Ratify the appointment of EisnerAmper LLP as Celularity’s independent registered public accounting firm for the fiscal year ending December 31, 2025; stockholder ratification is not required but recommended for corporate governance.
Amend the Celularity 2021 Equity Incentive Plan to increase the share reserve by 3,500,000 shares (from 2,? to 4,479,204 as described in the proxy); the amendment is intended to ensure continued equity awards for employees and non-employee directors, with plan features summarized in the proxy.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | C V STARR CO INC | 2.6% | 764,069 | $2M |
| 2 | VANGUARD GROUP INC | 2.1% | 594,461 | $660K |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 0.5% | 134,125 | $149K |
| 4 | VANGUARD GROUP INC | 0.3% | 79,874 | $89K |
| 5 | CITADEL ADVISORS LLC | 0.3% | 77,657 | $86K |
| 6 | BlackRock, Inc. | 0.3% | 76,359 | $85K |
| 7 | STATE STREET CORP | 0.2% | 57,830 | $64K |
| 8 | Valmark Advisers, Inc. | 0.2% | 49,983 | $55K |
| 9 | NORTHERN TRUST CORP | 0.2% | 44,163 | $49K |
| 10 | JANE STREET GROUP, LLC | 0.1% | 41,039 | $46K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.